MedTrace Logo

Antioxidation Medication for Noise-induced Hearing Loss

NCT00552786 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 53

Last updated 2010-07-27

Study results available
· View outcomes & findings →

Summary

This study will examine whether oral intake of 1200mg N-Acetylcysteine/day will prevent temporary threshold shift in hearing among workers exposed to noise

Conditions

Interventions

DRUG

N-acetylcysteine (NAC)

600mg twice daily for 2 weeks

DRUG

glucose

1 gm glucose capsule

Sponsors & Collaborators

  • Institute of Occupational Safety and Health, Taiwan

    collaborator UNKNOWN

  • Municipal Hospital of Tainan, Taiwan

    collaborator UNKNOWN

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Yue-Liang L Guo, MD, MPH, PHD · National Taiwan University Hospital

  • Tung-Sheng Shih, PHD · Institute of Occupational Safety and Health, Taiwan

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-11-30
Primary Completion
2008-01-31
Completion
2008-03-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00552786 on ClinicalTrials.gov